Physician-led Online Healthcare Technology Company Applies for Novel Clinical Trial for COVID-19 Using Medical Cannabis


You May Also Like

G1 Therapeutics Secures $47 Million Series C Financing

Proceeds will advance lead CDK4/6 inhibitors through early and mid-stage clinical trials, expand pipeline ...

ASLAN Pharmaceuticals Announces Strategic Prioritisation of Clinical Development Programs and Corporate Restructuring

SINGAPORE, Jan. 29, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology-focused ...